Astrana Health Financials
ASTH Stock | 43.25 0.39 0.91% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.34 | 0.4533 |
|
| |||||
Current Ratio | 2.02 | 2.1105 |
|
|
Investors should never underestimate Astrana Health's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Astrana Health's cash flow, debt, and profitability to make informed and accurate decisions about investing in Astrana Health.
Net Income |
|
Astrana | Select Account or Indicator |
Understanding current and past Astrana Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Astrana Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Astrana Health's assets may result in an increase in income on the income statement.
Astrana Health Stock Summary
Astrana Health competes with Xunlei, Ambev SA, Global E, Coca Cola, and Fluent. Astrana Health is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US03763A2078 |
CUSIP | 03763A207 03763A108 |
Older Symbol | AMEH |
Location | California; U.S.A |
Business Address | 1668 S Garfield |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.astranahealth.com |
Phone | 626 282 0288 |
Astrana Health Key Financial Ratios
Return On Equity | 0.1 | ||||
Profit Margin | 0.04 % | ||||
Operating Margin | 0.06 % | ||||
Price To Sales | 1.15 X | ||||
Revenue | 1.39 B |
Astrana Health Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 728.7M | 817.5M | 867.4M | 966.2M | 933.4M | 980.0M | |
Other Current Liab | 77.0M | 74.1M | 88.5M | 128.5M | 184.1M | 193.3M | |
Net Debt | 153.3M | 67.1M | (32.1M) | (58.7M) | 27.2M | 28.6M | |
Retained Earnings | 31.9M | 69.8M | 137.2M | 182.4M | 243.1M | 255.3M | |
Accounts Payable | 6.9M | 9.6M | 5.5M | 10.5M | 9.1M | 9.5M | |
Cash | 103.3M | 193.5M | 233.1M | 288.0M | 293.8M | 308.5M | |
Total Liab | 367.7M | 372.3M | 356.7M | 407.7M | 522.6M | 548.7M | |
Total Current Assets | 329.1M | 338.6M | 404.5M | 428.1M | 461.5M | 484.6M | |
Common Stock | 35.9K | 42K | 45K | 47K | 54.1K | 33.4K | |
Short Term Debt | 12.6M | 14.2M | 3.9M | 4.8M | 24.8M | 26.0M | |
Net Receivables | 99.0M | 60.6M | 99.3M | 119.7M | 147.8M | 155.1M | |
Other Current Assets | 10.3M | 16.8M | 18.6M | 14.8M | 17.5M | 18.3M | |
Net Tangible Assets | 18.8M | 119.0M | 118.7M | 214.0M | 246.1M | 258.4M | |
Other Assets | 2.4M | 55.3M | 6.5M | 6.1M | 22.1M | 12.9M | |
Long Term Debt | 232.2M | 230.2M | 182.9M | 203.4M | 258.9M | 271.9M | |
Good Will | 238.5M | 239.1M | 246.4M | 269.1M | 278.8M | 139.8M | |
Long Term Debt Total | 232.2M | 230.2M | 182.9M | 203.4M | 233.9M | 245.6M | |
Capital Surpluse | 159.6M | 261.0M | 310.9M | 360.1M | 414.1M | 434.8M | |
Intangible Assets | 103.0M | 87.0M | 82.8M | 76.9M | 71.6M | 56.4M |
Astrana Health Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 4.7M | 2.5M | 5.4M | 7.9M | 16.1M | 16.9M | |
Operating Income | 34.4M | 6.1M | 98.2M | 104.3M | 84.6M | 88.8M | |
Ebit | 34.4M | 187.9M | 83.1M | 94.5M | 105.9M | 111.2M | |
Income Before Tax | 25.8M | 8.9M | 77.7M | 86.6M | 89.8M | 94.3M | |
Net Income | 14.1M | (23.8M) | 68.9M | 45.2M | 60.7M | 63.8M | |
Ebitda | 52.7M | 206.3M | 100.7M | 112.1M | 123.7M | 129.9M | |
Income Tax Expense | 8.2M | 9.2M | 31.7M | 40.9M | 32.0M | 33.6M | |
Total Revenue | 560.6M | 370.2M | 773.9M | 1.1B | 1.4B | 1.5B | |
Cost Of Revenue | 486.1M | 348.5M | 596.1M | 944.7M | 1.2B | 1.2B | |
Gross Profit | 74.5M | 21.7M | 177.8M | 199.5M | 215.0M | 225.7M | |
Minority Interest | 3.6M | 84.5M | 24.6M | 1.5M | 2.9M | 2.7M | |
Tax Provision | 8.2M | 56.1M | 28.5M | 36.1M | 32.0M | 22.8M | |
Interest Income | 2.0M | 2.8M | 1.6M | 2.0M | 14.2M | 14.9M | |
Net Interest Income | (2.7M) | (6.7M) | (3.8M) | (5.9M) | (1.9M) | (2.0M) |
Astrana Health Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (3.6M) | 90.0M | 39.1M | 54.9M | 6.1M | 5.8M | |
Free Cash Flow | 12.6M | 45.0M | 51.1M | 59.2M | 39.7M | 41.7M | |
Other Non Cash Items | 5.3M | (102.1M) | 22.9M | 15.2M | 6.4M | 9.7M | |
Capital Expenditures | 1.0M | 1.2M | 19.2M | 22.9M | 28.5M | 30.0M | |
Net Income | 17.7M | 122.3M | 49.3M | 50.5M | 57.8M | 60.7M | |
End Period Cash Flow | 104.0M | 194.0M | 233.1M | 288.0M | 294.2M | 308.9M | |
Change To Inventory | (29.6M) | (5.8M) | 1.0M | 31.4M | 12.2M | 12.8M | |
Depreciation | 18.8M | 18.4M | 17.5M | 17.5M | 17.7M | 8.9M | |
Investments | (129.7M) | 108.0M | 32.4M | 34.3M | (65.5M) | (62.2M) | |
Change Receivables | (5.8M) | 15.6M | (26.8M) | (28.8M) | (25.9M) | (24.6M) | |
Net Borrowings | 281.4M | (105K) | (58.0M) | (828K) | (952.2K) | (904.6K) | |
Dividends Paid | 61.7M | 51.3M | 31.1M | 14.0M | 62.1M | 65.2M | |
Change To Netincome | 2.3M | (106.7M) | (2.0M) | (3.7M) | (3.3M) | (3.5M) |
Astrana Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Astrana Health's current stock value. Our valuation model uses many indicators to compare Astrana Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Astrana Health competition to find correlations between indicators driving Astrana Health's intrinsic value. More Info.Astrana Health is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Astrana Health is roughly 2.29 . As of now, Astrana Health's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Astrana Health's earnings, one of the primary drivers of an investment's value.Astrana Health Systematic Risk
Astrana Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Astrana Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Astrana Health correlated with the market. If Beta is less than 0 Astrana Health generally moves in the opposite direction as compared to the market. If Astrana Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Astrana Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Astrana Health is generally in the same direction as the market. If Beta > 1 Astrana Health moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Astrana Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Astrana Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Astrana Health growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Astrana Health December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Astrana Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Astrana Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Astrana Health based on widely used predictive technical indicators. In general, we focus on analyzing Astrana Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Astrana Health's daily price indicators and compare them against related drivers.
Information Ratio | (0.07) | |||
Maximum Drawdown | 26.75 | |||
Value At Risk | (3.68) | |||
Potential Upside | 5.28 |
Complementary Tools for Astrana Stock analysis
When running Astrana Health's price analysis, check to measure Astrana Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astrana Health is operating at the current time. Most of Astrana Health's value examination focuses on studying past and present price action to predict the probability of Astrana Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astrana Health's price. Additionally, you may evaluate how the addition of Astrana Health to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |